Authors:
HEDLEY LR
JACOBSON LO
SECCHI RL
KHABBAZ M
GOGAS KR
HUNTER JC
WHITING RL
Citation: Lr. Hedley et al., EFFECTS OF ENDOMORPHIN-1 AND ENDOMORPHIN-2 ON TAIL-FLICK LATENCY AND RESPIRATORY DEPRESSION IN RATS, The FASEB journal, 12(4), 1998, pp. 916-916
Authors:
STANLEY WC
LEE KH
JOHNSON LG
WHITING RL
EGLEN RM
HEGDE SS
Citation: Wc. Stanley et al., CARDIOVASCULAR EFFECTS OF NEPICASTAT (RS-25560-197), A NOVEL DOPAMINE-BETA-HYDROXYLASE INHIBITOR, Journal of cardiovascular pharmacology, 31(6), 1998, pp. 963-970
Authors:
STANLEY WC
LI B
BONHAUS DW
JOHNSON LG
LEE K
PORTER S
WALKER K
MARTINEZ G
EGLEN RM
WHITING RL
HEGDE SS
Citation: Wc. Stanley et al., CATECHOLAMINE MODULATORY EFFECTS OF NEPICASTAT (RS-25560-197), A NOVEL, POTENT AND SELECTIVE INHIBITOR OF DOPAMINE-BETA-HYDROXYLASE, British Journal of Pharmacology, 121(8), 1997, pp. 1803-1809
Authors:
WHITING RL
STANLEY WC
BONHAUS D
JOHNSON LG
LEE K
PORTER S
WALKER K
EGLEN RM
HEGDE SS
Citation: Rl. Whiting et al., PHARMACOLOGY OF RS-25560-197, A NOVEL AND SELECTIVE INHIBITOR OF DOPAMINE-BETA-HYDROXILASE, British Journal of Pharmacology, 120, 1997, pp. 170-170
Authors:
TERRY AV
BUCCAFUSCO JJ
PRENDERGAST MA
JACKSON WJ
FONTANA DL
WONG EHF
WHITING RL
EGLEN RM
Citation: Av. Terry et al., THE 5-HT3 RECEPTOR ANTAGONIST, RS-56812, ENHANCES DELAYED MATCHING PERFORMANCE IN MONKEYS, NeuroReport, 8(1), 1996, pp. 49-54
Authors:
HEGDE SS
STANLEY WC
LEE K
PORTER S
WALKER K
MARTINEZ G
EGLEN RM
WHITING RL
Citation: Ss. Hegde et al., CATECHOLAMINE MODULATORY AND CARDIOVASCULAR EFFECTS OF RS-25560-197, A NOVEL AND POTENT INHIBITOR OF DOPAMINE-BETA-HYDROXYLASE, Circulation, 94(8), 1996, pp. 2362-2362
Authors:
HEGDE SS
STANLEY WC
LEE K
WALKER K
MARTINEZ G
EGLEN RM
WHITING RL
Citation: Ss. Hegde et al., SYNERGISTIC HEMODYNAMIC-EFFECTS OF A DOPAMINE-BETA-HYDROXYLASE INHIBITOR (RS-25560-197) AND ACE-INHIBITOR (ENALAPRIL) IN SPONTANEOUSLY HYPERTENSIVE RATS, Circulation, 94(8), 1996, pp. 2780-2780
Authors:
FISHER LE
ROSENKRANZ RP
CLARK RD
MUCHOWSKI JM
MCCLELLAND DL
MICHEL A
CAROON JM
GALEAZZI E
EGLEN R
WHITING RL
Citation: Le. Fisher et al., 6-BIS-[2-(3,4-DIHYDROXYBENZYL)PYRROLIDINYL]HEXANE, A POTENT, SELECTIVE, ORALLY-ACTIVE DOPAMINE ANALOG WITH HYPOTENSIVE AND DIURETIC ACTIVITY, Bioorganic & medicinal chemistry letters, 5(20), 1995, pp. 2371-2376
Authors:
SHARIF NA
NUNES JL
ROSENKRANZ RP
WHITING RL
EGLEN RM
Citation: Na. Sharif et al., QUANTITATIVE AUTORADIOGRAPHY DEMONSTRATES SELECTIVE MODULATION OF RAT-BRAIN REGIONAL DOPAMINE (D-1 AND D-2) RECEPTOR SUBTYPES AFTER CHRONICMANIPULATION OF DIETARY SALT, Neurochemical research, 20(2), 1995, pp. 121-128
Authors:
SHARIF NA
TO ZP
WONG KH
DELMENDO RE
WHITING RL
EGLEN RM
Citation: Na. Sharif et al., M(3) MUSCARINIC RECEPTORS ON MURINE HSDM1C1 CELLS - FURTHER FUNCTIONAL, REGULATORY, AND RECEPTOR-BINDING STUDIES, Neurochemical research, 20(1), 1995, pp. 61-68
Authors:
SHARIF NA
NUNES JL
LAKE KD
MCCLELLAND DL
CORKINS SF
LAKATOS I
ROSENKRANZ RP
WHITING RL
EGLEN RM
Citation: Na. Sharif et al., CHRONIC MANIPULATION OF DIETARY SALT MODULATES RENAL PHYSIOLOGY AND KIDNEY DOPAMINE-RECEPTOR SUBTYPES - FUNCTIONAL AND AUTORADIOGRAPHIC STUDIES, General pharmacology, 26(4), 1995, pp. 727-735
Authors:
WONG EHF
CLARK R
LEUNG E
LOURY D
BONHAUS DW
JAKEMAN L
PARNES H
WHITING RL
EGLEN RM
Citation: Ehf. Wong et al., THE INTERACTION OF RS-25259-197, A POTENT AND SELECTIVE ANTAGONIST, WITH 5-HT3 RECEPTORS, IN-VITRO, British Journal of Pharmacology, 114(4), 1995, pp. 851-859
Authors:
EGLEN RM
LEE CH
SMITH WL
JOHNSON LG
CLARK R
WHITING RL
HEGDE SS
Citation: Rm. Eglen et al., PHARMACOLOGICAL CHARACTERIZATION OF RS-25259-197, A NOVEL AND SELECTIVE 5-HT3 RECEPTOR ANTAGONIST, IN-VIVO, British Journal of Pharmacology, 114(4), 1995, pp. 860-866
Authors:
EGLEN RM
BONHAUS DW
CLARK RD
JOHNSON LG
LEE CH
LEUNG E
SMITH WL
WONG EHF
WHITING RL
Citation: Rm. Eglen et al., (R)-RS-56532 AND (S)-RS-56532 - MIXED 5-HT3 AND 5-HT4 RECEPTOR LIGANDS WITH WITH OPPOSING ENANTIOMERIC SELECTIVITY, Neuropharmacology, 33(3-4), 1994, pp. 515-526
Authors:
EGLEN RM
LEE CH
SMITH WL
JOHNSON LG
WHITING RL
HEGDE SS
Citation: Rm. Eglen et al., RS-42358-197, A NOVEL AND POTENT 5-HT3 RECEPTOR ANTAGONIST, IN-VITRO AND IN-VIVO, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 535-543
Authors:
LEUNG E
ALVAREZ R
BONHAUS DW
CLARK RD
JOHNSON LG
LEE CH
SMITH WL
WONG EHF
WHITING RL
EGLEN RM
Citation: E. Leung et al., (R)56532 AND (S)56532 - MIXED 5-HT(3) AND 5-HT(4) RECEPTOR LIGANDS WITH OPPOSING ENANTIOMERIC SELECTIVITY, British Journal of Pharmacology, 110, 1993, pp. 160000134-160000134